Inogen

168 articles with Inogen

• Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum

  3/8/2023

  Inogen, Inc. today announced that management will participate in a virtual fireside chat at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. Eastern Time.

• Inogen to Provide Strategy Update on February 27, 2023

  2/23/2023

  Inogen, Inc. today announced that it will host a conference call on Monday, February 27, 2023, at 10:00 a.m. Eastern Time.

• Inogen Announces Fourth Quarter and Full Year 2022 Financial Results

  2/23/2023

  Inogen, Inc today announced financial results for the fourth quarter and the full year ended December 31, 2022.

• Inogen Achieves Regulatory Milestones to Support Current and Future Products

  1/10/2023

  Inogen, Inc. announced that it has achieved regulatory milestones in the EU and the US to support its portable oxygen concentrator products.

• Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations

  1/10/2023

  Inogen, Inc. today announced unaudited preliminary revenue results for the fourth quarter and the full year ended December 31, 2022.

• Inogen to Present at 41st Annual J.P. Morgan Healthcare Conference

  12/13/2022

  Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.

• Inogen to Present at Upcoming Investor Conferences in November 2022

  11/4/2022

  Inogen, Inc announced that management will present at the following investor conferences: Stifel 2022 Healthcare Conference on Tuesday, November 15 at 10:20 a.m. Eastern Time Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30 at 11:30 a.m. Eastern Time A live webcast and archived recording of each presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website.

• Inogen Announces Third Quarter 2022 Financial Results

  11/2/2022

  Inogen, Inc. today announced financial results for the quarter ended September 30, 2022, and provided a business update.

• Inogen to Announce Third Quarter 2022 Financial Results on November 2, 2022

  10/5/2022

  Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third quarter 2022 financial results before the market opens on Wednesday, November 2, 2022.

• Inogen Announces Second Quarter 2022 Financial Results

  8/4/2022

  Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2022 and provided a business update.

• Inogen to Announce Second Quarter 2022 Financial Results on August 4, 2022

  7/7/2022

  Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2022 financial results after market close on Thursday, August 4, 2022.

• Inogen Names Agnes Lee as Senior Vice President of Investor Relations and Strategic Planning

  5/18/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Agnes Lee to the position of Senior Vice President of Investor Relations and Strategic Planning, effective May 23, 2022.

• Inogen Announces First Quarter 2022 Financial Results

  5/5/2022

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 2022.

• Inogen to Announce First Quarter 2022 Financial Results on May 5, 2022

  4/14/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022.

• Inogen Announces Participation in the 21st Annual Needham Virtual Healthcare Conference

  3/30/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that the Company’s management will be participating in the 21st Annual Needham Virtual Healthcare Conference.

• Inogen Announces Board of Director Changes

  3/23/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Glenn Boehnlein, Kevin King, and Mary Katherine Ladone to Inogen’s Board of Directors, effective March 22, 2022.

• Inogen Names Kristin Caltrider as Chief Financial Officer

  3/4/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Kristin Caltrider as EVP & Chief Financial Officer, effective March 21, 2022.

• Inogen Announces Fourth Quarter and Full Year 2021 Financial Results

  2/24/2022

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three- and twelve-month periods ended December 31, 2021.

• Inogen to Announce Fourth Quarter 2021 Financial Results on February 24, 2022

  1/26/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter 2021 financial results after market close on Thursday, February 24, 2022.

• Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results

  1/10/2022

  Inogen, Inc. today reported preliminary, unaudited revenue results for the three-month and twelve-month periods ended December 31, 2021.